Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

58.69
+0.24000.41%
Volume:164.13K
Turnover:9.63M
Market Cap:5.50B
PE:24.99
High:59.19
Open:58.87
Low:58.47
Close:58.45
52wk High:71.24
52wk Low:48.26
Shares:93.67M
Float Shares:58.75M
Volume Ratio:0.43
T/O Rate:0.28%
Dividend:1.44
Dividend Rate:2.45%
EPS(TTM):2.35
EPS(LYR):2.62
ROE:8.76%
ROA:5.15%
PB:2.13
PE(LYR):22.40

Loading ...

Cognition Therapeutics Advances Zervimesine Toward Phase 3 DLB Trial

TIPRANKS
·
Jun 04

Dolby SVP Entertainment John Couling sells 7,666 shares for $426,115.12

Reuters
·
Jun 04

Wall Street Analysts Are Bullish on Top Industrial Goods Picks

TIPRANKS
·
Jun 04

A Look At Dolby Laboratories (DLB) Valuation After Weak Guidance Offsets Revenue Beat

Simply Wall St.
·
Jun 02

Cognition Therapeutics Participating in Upcoming Investor Conferences

GlobeNewswire
·
Jun 01

Dolby expands rednote collaboration with Dolby Atmos video support

Reuters
·
May 29

Analysts Offer Insights on Industrial Goods Companies: Dolby Laboratories (DLB) and Electro Optic Systems Holdings Limited (OtherEOPSF)

TIPRANKS
·
May 27

A Look At Dolby Laboratories (DLB) Valuation After Recent Share Price Pullback

Simply Wall St.
·
May 21

Cognition Therapeutics Advances Zervimesine Toward Late-Stage DLB Trial

TIPRANKS
·
May 21

Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis

GlobeNewswire
·
May 21

Dolby SVP Shriram Revankar disposes 7,329 shares worth $401,901.09

Reuters
·
May 20

Dolby CEO Yeaman presents at William Blair Growth Stock Conference

Reuters
·
May 20

Boris Peaker Reiterates Buy on Neflamapimod Developer, Backs $20 Price Target on Pivotal DLB Phase III and Broad 2026 Clinical Catalysts

TIPRANKS
·
May 19

Press Release: Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Dow Jones
·
May 14

Is Dolby (DLB) Using Buybacks And Dividends To Quietly Redefine Its Premium Audio Strategy?

Simply Wall St.
·
May 11

Press Release: Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update

Dow Jones
·
May 08

Dolby SVP John Couling sells Class A shares worth $720,349.45

Reuters
·
May 07

Is Dolby (DLB) Quietly Redefining Its Moat Through In‑Car Dolby Atmos And Steady Profitability?

Simply Wall St.
·
May 04

Analysts Offer Insights on Industrial Goods Companies: Dolby Laboratories (DLB) and Proto Labs (PRLB)

TIPRANKS
·
May 02

Dolby Laboratories Down Over 12%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Dow Jones
·
May 01